About Policy Issues Scientific Innovation Patient Support News Resources Blog Sites News Room Search Recent Press Releases New Analysis Confirms Government Price Setting Leads to Reduction in R&D Investment and Delayed Access to Medicines NOV 23, 2021 A new analysis out today adds to a growing body of research showing that government price setting has a devastating impact on biopharmaceutical research and development and places an additional barrier between patients and innovative medicines. House Drug Pricing Plan Will “Throw Sand in the Gears of Medical Progress” NOV 19, 2021 The consequences of this heavy-handed drug pricing plan will make a broken insurance system worse and throw sand in the gears of medical progress Five Key Strategies for Enhancing Diversity in Clinical Trials NOV 16, 2021 A new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Deloitte Center for Health Solutions (CHS) outlines five critical strategies for enhancing diversity in clinical trials during the research and development of new medicines. PhRMA Statement on the Nomination of Dr. Robert Califf to Lead the U.S. Food and Drug Administration NOV 12, 2021 “Congratulations to Dr. Robert Califf for being nominated as the next commissioner of the U.S. Food and Drug Administration Latest Drug Pricing Proposal “Not the Balanced Approach We Need” NOV 8, 2021 “This drug pricing plan is not the balanced approach we need to build a better, more affordable health care system. Instead, it will make a broken system even worse PhRMA Statement on Democrats' Drug Pricing Deal in Reconciliation Package NOV 2, 2021 The following statement on the Demoncrats' Drug Pricing Deal can be attributed to PhRMA President and CEO Stephen J. Ubl. In Honor of Visionary Leader, PhRMA Announces the Kenneth C. Frazier PhRMA Scholars Program OCT 21, 2021 In honor of retiring PhRMA board member and visionary industry leader Ken Frazier, PhRMA today announced The Kenneth C. Frazier PhRMA Scholars Program to provide college scholarships to academically high achieving, low-income students in Washington, D.C. and in Ken’s hometown of Philadelphia, Pennsylvania. New Survey Reveals Insurance Design Leads to Access and Affordability Issues for Most Vulnerable Patients OCT 7, 2021 Patients with serious chronic diseases report major challenges in getting the right medication because of insurance practices that force them to fail on less expensive medications first, and minority populations suffer disproportionately, according a new survey by PhRMA examining barriers people face in accessing health care and prescription medicines. STAY CONNECTED > SHARE MEMBERS SITE CONTACT US PRIVACY POLICY TERMS OF SERVICE SITE MAP Pharmaceutical Research and Manufacturers of America® 950 F Street, NW Suite 300, Washington, DC 20004 Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review "1. Information Collection."